Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)

China flag China · Delayed Price · Currency is CNY
16.31
-0.26 (-1.57%)
At close: Feb 27, 2026
-18.86%
Market Cap 32.25B
Revenue (ttm) 6.42B
Net Income (ttm) 1.32B
Shares Out 1.98B
EPS (ttm) 0.66
PE Ratio 24.73
Forward PE 19.53
Dividend 0.15 (0.92%)
Ex-Dividend Date Sep 25, 2025
Volume 15,647,870
Average Volume 11,208,382
Open 16.54
Previous Close 16.57
Day's Range 16.31 - 16.55
52-Week Range 16.06 - 23.61
Beta 0.27
RSI 41.47
Earnings Date Mar 28, 2026

About SHA:600161

Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and marketing of blood products in China and internationlly. Its products include human albumin; intravenous human immunoglobulin; rabies patient immunoglobulin; tetanus human immunoglobulin; hepatitis B human immunoglobulin; freeze-dried intravenous hepatitis B human immunoglobulin; histamine human immunoglobulin; human prothrombin complex; human coagulation factors VIII; human fibrinogen; recombinant human coagulation factor VIII for inje... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1966
Employees 5,298
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600161
Full Company Profile

Financial Performance

In 2024, SHA:600161's revenue was 6.03 billion, an increase of 16.44% compared to the previous year's 5.18 billion. Earnings were 1.55 billion, an increase of 39.58%.

Financial Statements

News

There is no news available yet.